Question 1

What is the catalog number for Human hsa-miR-4446-3p miRNA Agomir?

Accepted Answer

The catalog number for Human hsa-miR-4446-3p miRNA Agomir is abx881258.

Question 2

What sizes are available for Human hsa-miR-4446-3p miRNA Agomir?

Accepted Answer

Human hsa-miR-4446-3p miRNA Agomir is available in the following size(s): 5 nmol, 10 nmol.

Question 3

How many pack sizes does Human hsa-miR-4446-3p miRNA Agomir come in?

Accepted Answer

Human hsa-miR-4446-3p miRNA Agomir is available in 2 different pack sizes.

Question 4

Is Human hsa-miR-4446-3p miRNA Agomir in stock?

Accepted Answer

Human hsa-miR-4446-3p miRNA Agomir is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 7

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Human hsa-miR-4446-3p miRNA Agomir

Product Specifications

Notes

Host or Source

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-Transferrin/TF Antibody Picoband® (Dylight488 Conjugate)

Human CCL8/MCP-2 ELISA Kit PicoKine®

Bcl-2 (100/D5 + 124), CF405S conjugate, 0.1mg/mL

Human Ki67 ELISA Kit PicoKine®

MCM6 (Proliferation Marker) (MCM6/3000), CF740 conjugate, 0.1mg/mL

Anti-CYP24A1 Antibody Picoband® (FITC Conjugate)